GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Outset Medical Inc (NAS:OM) » Definitions » Piotroski F-Score

Outset Medical (Outset Medical) Piotroski F-Score : 3 (As of Apr. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Outset Medical Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Outset Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Outset Medical's Piotroski F-Score or its related term are showing as below:

OM' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 4
Current: 3

During the past 6 years, the highest Piotroski F-Score of Outset Medical was 4. The lowest was 2. And the median was 3.


Outset Medical Piotroski F-Score Historical Data

The historical data trend for Outset Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Outset Medical Piotroski F-Score Chart

Outset Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 4.00 2.00 3.00

Outset Medical Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 4.00 3.00 3.00

Competitive Comparison of Outset Medical's Piotroski F-Score

For the Medical Devices subindustry, Outset Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Outset Medical's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Outset Medical's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -43.971 + -44.046 + -46.18 + -38.6 = $-172.8 Mil.
Cash Flow from Operations was -44.756 + -28.176 + -33.999 + -24.442 = $-131.4 Mil.
Revenue was 33.467 + 36.04 + 30.362 + 30.507 = $130.4 Mil.
Gross Profit was 6.428 + 7.703 + 7.157 + 7.712 = $29.0 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(400.115 + 362.665 + 334.442 + 307.551 + 313.801) / 5 = $343.7148 Mil.
Total Assets at the begining of this year (Dec22) was $400.1 Mil.
Long-Term Debt & Capital Lease Obligation was $134.6 Mil.
Total Current Assets was $291.2 Mil.
Total Current Liabilities was $55.3 Mil.
Net Income was -36.892 + -43.839 + -40.781 + -41.444 = $-163.0 Mil.

Revenue was 30.55 + 25.057 + 27.761 + 32.007 = $115.4 Mil.
Gross Profit was 4.442 + 3.782 + 4.336 + 5.273 = $17.8 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(463.464 + 431.742 + 401.236 + 365.722 + 400.115) / 5 = $412.4558 Mil.
Total Assets at the begining of last year (Dec21) was $463.5 Mil.
Long-Term Debt & Capital Lease Obligation was $101.9 Mil.
Total Current Assets was $373.6 Mil.
Total Current Liabilities was $51.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Outset Medical's current Net Income (TTM) was -172.8. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Outset Medical's current Cash Flow from Operations (TTM) was -131.4. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-172.797/400.115
=-0.43186834

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-162.956/463.464
=-0.35160444

Outset Medical's return on assets of this year was -0.43186834. Outset Medical's return on assets of last year was -0.35160444. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Outset Medical's current Net Income (TTM) was -172.8. Outset Medical's current Cash Flow from Operations (TTM) was -131.4. ==> -131.4 > -172.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=134.595/343.7148
=0.39158919

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=101.912/412.4558
=0.24708587

Outset Medical's gearing of this year was 0.39158919. Outset Medical's gearing of last year was 0.24708587. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=291.219/55.323
=5.26397701

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=373.645/51.949
=7.19253499

Outset Medical's current ratio of this year was 5.26397701. Outset Medical's current ratio of last year was 7.19253499. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Outset Medical's number of shares in issue this year was 50.26. Outset Medical's number of shares in issue last year was 49.139. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=29/130.376
=0.22243358

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=17.833/115.375
=0.15456555

Outset Medical's gross margin of this year was 0.22243358. Outset Medical's gross margin of last year was 0.15456555. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=130.376/400.115
=0.32584632

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=115.375/463.464
=0.24894059

Outset Medical's asset turnover of this year was 0.32584632. Outset Medical's asset turnover of last year was 0.24894059. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Outset Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Outset Medical  (NAS:OM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Outset Medical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Outset Medical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Outset Medical (Outset Medical) Business Description

Traded in Other Exchanges
N/A
Address
3052 Orchard Drive, San Jose, CA, USA, 95134
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
Executives
Leslie Trigg director, officer: President & CEO C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Marc Nash officer: SVP, Operations and R&D 3052 ORCHARD DRIVE, SAN JOSE CA 95134
Jean-olivier Racine officer: Chief Technology Officer 3052 ORCHARD DRIVE, SAN JOSE CA 95134
Nabeel Ahmed officer: Interim CFO 3052 ORCHARD DRIVE, SAN JOSE CA 95134
Stacey L. Porter officer: Chief People Officer 3052 ORCHARD DRIVE, SAN JOSE CA 95134
John L. Brottem officer: General Counsel 3052 ORCHARD DR., SAN JOSE CA 95134
Steven S. Williamson officer: Chief Commercial Officer C/O HOLOGIC, INC., BEDFORD MA 01730
Martin Vazquez officer: Chief Operating Officer 3052 ORCHARD DR., SAN JOSE CA 95134
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Dale E Jones director C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801
D Keith Grossman director
Rebecca Chambers officer: Chief Financial Officer 3052 ORCHARD DR., SAN JOSE CA 95134
Catherine M. Szyman director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Warburg Pincus Llc director, 10 percent owner 450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus X, L.p. director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017